Sunshine Biopharma Inc. (SBFM)
NASDAQ · Healthcare
Sunshine Biopharma Inc. EPS 2017–2025
Sunshine Biopharma Inc. annual/quarterly eps history and growth rate from 2021 to 2025. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Sunshine Biopharma Inc. eps for the quarter ending June 30, 2025 was $0.82, a 98.11% decrease year-over-year.
- Sunshine Biopharma Inc. annual eps for 2024 was $7.32, a 97.92% decrease from 2023.
- Sunshine Biopharma Inc. annual eps for 2023 was $351.36, a 19863.64% increase from 2022.
- Sunshine Biopharma Inc. annual eps for 2022 was $1.76, a 63.03% decrease from 2021.
- Sunshine Biopharma Inc. annual eps for 2021 was $4.76.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Sunshine Biopharma Inc. EPS — FAQ
Sunshine Biopharma Inc. (SBFM) eps over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SBFM's eps history?
The chart and table above show Sunshine Biopharma Inc.'s eps by year and by quarter, including the growth rate.